home / stock / mrk / mrk articles

MRK Articles, Merck & Company Inc. - From 05/03/24

Stock Information
Company Name: Merck & Company Inc.
Stock Symbol: MRK
Market: NYSE
Website: merck.com
Menu
MRK MRK Quote MRK Short MRK News MRK Articles MRK Message Board
Get MRK Alerts

News, Short Squeeze, Breakout and More Instantly...
Serum Institute of India Inks Large-Scale Supply Deal For BCG Use In ImmunityBio's Bladder Cancer Combo Therapy | Benzinga

ImmunityBio Inc (NASDAQ:IBRX) shares are trading down after an early morning high on Friday after the company announced an exclusive global arrang...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration | Benzinga

After topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co Inc (NYSE: MRK) just reported encouragin...

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week | Benzinga

Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it r...

Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points | Benzinga

The CNN Money Fear and Greed index showed a slight improvement in the overall market sentiment, while the index remained in the “Fear” ...
S&P 500 Down Over 1%; Merck Increases 2024 Outlook | Benzinga

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling by around 250 points on Thursday. The Dow traded down 1.55% to 3...

US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst | Benzinga

The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platforms, Inc.’s (NA...

Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday? | Benzinga

Wednesday, Immutep Limited (NASDAQ:IMMP) released preliminary topline results from Cohort B of the TACTI-003 (KEYNOTE-PNC-34) P...
Exploring Analyst Estimates for Merck Q1 Earnings, Beyond Revenue and EPS | Benzinga

Wall Street analysts forecast that Merck (NYSE: MRK) will report quarterly earnings of $2.01 per share in its upcoming release, pointing to a year-...

Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week | Benzinga

As the market runs into rough weather, the importance of the upcoming week’s earnings cannot be emphasized enough. A lot is riding on the ear...

Declining COVID-19 Vaccine Sales Pinches Moderna, Pauses Kenya Vaccine Plant Plans | Benzinga

Famed COVID-19 vaccine maker Moderna Inc (NASDAQ:MRNA) has decided to pause its plans to construct a vaccine manufacturing...
Previous 10 Next 10